Drug
CD7 CAR-T cells injection
CD7 CAR-T cells injection is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph early_phase_1
3
75%
Ph phase_1
1
25%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
3(75.0%)
Phase 1Safety & dosage
1(25.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 13 (75.0%)
Phase 11 (25.0%)
Trials by Status
recruiting4100%
Recent Activity
4 active trials
Showing 4 of 4
recruitingphase_1
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
NCT05827835
recruitingearly_phase_1
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
NCT06787560
recruitingearly_phase_1
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD
NCT06769191
recruitingearly_phase_1
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
NCT06633328
Clinical Trials (4)
Showing 4 of 4 trials
NCT05827835Phase 1
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
NCT06787560Early Phase 1
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
NCT06769191Early Phase 1
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD
NCT06633328Early Phase 1
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4